PRKAB1 and neoplasm: In the light of this special issue “Cancer Biology in Diabetes”, it should be noted that AMPK activators such as AICAR and metformin can inhibit tumor cell growth [40,44,45,46,47], and metformin has been used in some clinical trials [45,48].